东印度尼西亚西帝汶中低度疟疾传播区大规模筛查与治疗对传播影响甚微:整群随机试验
在东印度尼西亚西帝汶中低度疟疾传播区开展整群随机试验,评估大规模筛查与治疗(MST)对疟疾发病率的影响。MST3组6个集群、MST2组5个集群、MST0组5个集群,324名学龄儿童队列中,MST3或MST2相对MST0的显微镜确诊疟疾发病密度风险比分别为1.00(95%CI 0.53-1.91)和1.22(95%CI 0.42-3.55)。结论:3个月内2或3轮MST未影响按蚊传播力,高比例未治疗的显微镜下亚 patent 感染可能解释其效果不佳。
要点
- 3个月内2或3轮MST未降低显微镜确诊疟疾发病密度。
- MST3组风险比1.00(95%CI 0.53-1.91),MST2组1.22(95%CI 0.42-3.55),均未达统计学显著。
- 显微镜下亚 patent 且未治疗的感染占感染者的72%。
核心结论
- 3个月内2或3轮MST未影响这些社区中按蚊传播的感染力。
- 显微镜下亚 patent 感染的高比例未治疗率可能解释观察到的效果不佳。
研究设计与样本
- 整群随机试验,评估有和无MST的疟疾发病率。
- 集群随机分为3轮MST(MST3,6个集群,156户/670人)、2轮MST(MST2,5个集群,89户/423人)或无MST(MST0,5个集群,174户/777人)。
- 所有集群完成研究,14名居民退出。
- 324名入组时显微镜阴性的学龄儿童队列(MST3组n=124;MST2组n=57;MST0组n=143),评估MST 3个月期间及之后3个月的疟疾发病密度。
- MST干预包括社区范围专家疟疾显微镜筛查,对葡萄糖-6-磷酸脱氢酶正常者给予双氢青蒿素-哌喹和伯氨喹标准治疗。
主要发现
- MST3组相对MST0组显微镜确诊疟疾发病密度风险比为1.00(95%CI 0.53-1.91)。
- MST2组相对MST0组显微镜确诊疟疾发病密度风险比为1.22(95%CI 0.42-3.55)。
- 分子分析和种特异性(恶性疟原虫和间日疟原虫)感染获得相似结果。
- 显微镜下亚 patent 且未治疗的感染占感染者的72%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Mass screening and treatment (MST) aims to reduce malaria risk in communities by identifying and treating infected persons without regard to illness. METHODS: A cluster-randomized trial evaluated malaria incidence with and without MST. Clusters were randomized to 3, 2, or no MST interventions: MST3, 6 clusters (156 households/670 individuals); MST2, 5 clusters (89 households/423 individuals); and MST0, 5 clusters (174 households/777 individuals). All clusters completed the study with 14 residents withdrawing. In a cohort of 324 schoolchildren (MST3, n = 124; MST2, n = 57; MST0, n = 143) negative by microscopy at enrollment, we evaluated the incidence density of malaria during 3 months of MST and 3 months following. The MST intervention involved community-wide expert malaria microscopic screening and standard therapy with dihydroartemisinin-piperaquine and primaquine for glucose-6 phosphate dehydrogenase-normal subjects. All blood examinations included polymerase chain reaction assays, which did not guide on-site treatment. RESULTS: The risk ratios for incidence density of microscopically patent malaria in MST3 or MST2 relative to that in MST0 clusters were 1.00 (95% confidence interval [CI], .53-1.91) and 1.22 (95% CI, .42-3.55), respectively. Similar results were obtained with molecular analysis and species-specific (P. falciparum and P. vivax) infections. Microscopically subpatent, untreated infections accounted for 72% of those infected. CONCLUSIONS: Two or 3 rounds of MST within 3 months did not impact the force of anopheline mosquito-borne infection in these communities. The high rate of untreated microscopically subpatent infections likely explains the observed poor impact. CLINICAL TRIALS REGISTRATION: NCT01878357.
引用
- Sutanto I, Kosasih A, Elyazar IRF, et al. Negligible Impact of Mass Screening and Treatment on Mesoendemic Malaria Transmission at West Timor in Eastern Indonesia: A Cluster-Randomized Trial. Clin Infect Dis. 2018. PMID: 29579195. doi:10.1093/cid/ciy231
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。